CLONING AND EXPRESSION OF FUSION PROTEIN GLUTATHION S TRANSFERASE-STREPTAVIDIN ON Bacillus subtilis SPORES AND EVALUATION OF ITS SPECIFIC BINDING WITH BIOTINYLATED ANTIBODY CETUXIMAB by Thu Thuỷ, Bùi et al.
  
Tạp chí Khoa học và Công nghệ 52 (6) (2014) 711-720 
 
 
CLONING AND EXPRESSION OF FUSION PROTEIN 
GLUTATHION S TRANSFERASE-STREPTAVIDIN ON                    
Bacillus subtilis SPORES AND EVALUATION OF ITS SPECIFIC 
BINDING WITH BIOTINYLATED ANTIBODY CETUXIMAB  
Bui Thu Thuy1, Phan Huong Trang1, Nguyen Trang Hieu1, Tran Thi My1, 2,  
Phan Tuan Nghia1, Nguyen Thi Van Anh1, * 
1Key Laboratory of Enzyme and Protein Technology, VNU University of Science,                                 
334 Nguyen Trai, Hanoi 
2ANABIO Research & Development JSC, Van Khe new urban, Hadong, Hanoi 
*Email: vananhbiolab@gmail.com 
Received: 12 December 2013; Accepted for publication: 15 Jully 2014 
ABSTRACT 
We cloned fusion gene (cotB-gst-streptavidin), encoding three sequential proteins including 
membrane spore coat protein CotB, Glutathion S Transferase (GST), and streptavidin, into the 
chromosome of Bacillus subtilis PY79 to create recombinant strain named SA2. Expression of 
streptavidin on the outer coat of SA2 spores were confirmed by immunofluoresence using 
specific anti-streptavidin rabbit IgG and anti-rabbit IgG labeled Alexa546. The specific bindings 
of biotinylated cetuximab on spores of Bacillus subtilis SA1 (expressing CotB-streptavidin) and 
on Bacillus subtilis SA2 were detected by Western Immunoblotting. The data indicates that 
binding of biotinylated cetuximab on SA2 spores was slightly 1.4 fold higher than that on SA1 
spores, suggesting limited role of GST in enhancing the exposure of streptavidin for interaction 
with biotinylated cetuximab. 
Keywords: Bacillus subtilis spore; Glutathion S Transferase (GST), streptavidin, biotinylated 
cetuximab. 
1. INTRODUCTION 
The Bacillus subtilis spores have been used as models for expression of target proteins 
fused with membrane protein, such as CotB, CotC, CotE on the spore surface [1 - 3]. Due to the 
unique, distinguishing heat-stable feature of spores, a spore-based display system provides 
advantages relative to those based on the use of bacterial cells. There has been number of 
antigens selected as model proteins and successfully displayed on the spore surface by fusion to 
cotB: i) the non-toxic 459 amino acid C-terminal fragment of the tetanus toxin (TTFC), encoded 
by the tetC gene of Clostridium tetani [4]; ii) the 103 amino acid B subunit of the heat-labile 
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toxin of enterotoxigenic strains of Escherichia coli (LTB), encoded by the eltB gene [4];                    
iii) toxin A peptide of Clostridium difficile [5]. 
Recently, we have been successful in cloning and expression of a gene encoding a fusion 
protein of CotB and streptavidin on the surface of B. subtilis SA1 spores [6, 7]. The SA1 spores 
is bound specifically with biotinylated cetuximab, a chimeric IgG1 monoclonal antibody that 
targets the extracellular domain of Epidermal Growth Factor Receptor (EGFR) over expressed 
on the surface of 30 – 85 % colon cancer cell types, including cetuximab-sensitive HT29 cell 
lines [4, 8 - 10]. The binding constant of SA1 with cetuximab biotinylated is determined to be 
about 107 M-1, indicating the specific binding of streptavidin with biotinylated cetuximab [7].  
In this work, we further create another recombinant B. subtilis SA2 strain expressing fusion 
proteins of CotB, Glutathion S Transferase, and streptavidin (CotB-GST-streptavidin). GST has 
been known as famous tag protein which can increase solubility of its fused proteins. Here, GST 
is designed in connection between CotB and streptavidin, with the aim to enhance exposure of 
streptavidin on spore surface, toward the external environment for interaction with biotin or 
biotinylated molecules. The specific binding of biotinylated cetuximab on SA1 and SA2 is 
compared to prove actual role of GST in enhancing streptavidin-biotin interaction. 
2. MATERIALS AND METHODS 
2.1. Materials  
B. subtilis wild type strain PY79 (spo+) was used. All recombinant strains described here 
are isogenic derivatives of PY79. Plasmid amplification for nucleotide sequencing, sub-cloning 
experiments and CaCl2-mediated transformation of E. coli competent cells were performed in 
the E. coli strain DH5α as described in Sambrook et al., 1989 [11]. Methods for Bacillus 
including the two-step transformation of B. subtilis were those outlined in Cutting et al., 1990 
[12]. 
2..2 Methods 
2.2.1. Construction of gene fusions 
Using laboratory B. subtilis strain containing cotB-gst (kindly provided by Prof. Simon 
Cutting) and Streptomyces avidinii strain 11996 (NCIMB Ltd., Aberdeen, UK) as a chromosomal 
template, the complete ORF of cotB-gst, and ORF of streptavidin were amplified using 
respective primers (cotB forward: 5'-cgcggatccACGGATTAGGCCGTTTGTCCT-3' having a 
restriction site for BamHI, GST reverse: 5'-cccaagcttATCCGATTTTGGAGGATGGTTC-3' 
having a restriction site for HindIII, Strep forward, 5'-aaaaagcttGACCCCTCCAA 
GGACTCGAAG-3' having a restriction site for HindIII, and Strep reverse 5'-aaagaattc 
CTACTGCTGAACGGCGTCGAG-3' having a restriction site EcoRI). Purified PCR-amplified 
cotB-gst having the expected size of 1.7 kb was cleaved with BamHI and HindIII and cloned into 
pDG364. Then, purified PCR-amplified streptavidin DNA having the expected size of 500 bp 
was cleaved with HindIII and EcoRI and cloned into pDG364-cotB-gst. This created an in-frame 
fusion of cotB-gst with streptavidin at the HindIII site. The clone was verified using DNA 
sequencing across the fusion site and the plasmid was linearized by digestion with PstI. 
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Linearised DNA was then used to transform competent cells of B. subtilis strain PY79 with 
selection of chloramphenicol-resistant colonies. Transformants carried a stable, double 
crossover, insertion of the cotB-streptavidin chimera at the amylase gene (amyE) and the 
resulting clone named SA2 (Figure 1). 
2.2.2. Preparation of spores  
Sporulation of B. subtilis PY79 (spo+), the B. subtilis strains SA1 harbouring cotB-
streptavidin [6, 7], and SA2 harbouring cotB-gst-streptavidin (cotB-gst-SA) were made in DSM 
(Difco sporulation media) at 37 oC using the exhaustion method. Sporulating cultures were 
harvested 60h after the initiation of sporulation and suspensions of spores purified using 
lysozyme treatment to break any residual sporangial cells followed by washing in 1 M NaCl, 1M 
KCl and water [13]. The number of spores was calculated by serial dilution and plate counting. 
Spores were killed by autoclaving (120 oC, 15 psi, 20 mins). Water lost by evaporation was 
calculated and sterile water added to restore to the original volume before autoclaving using 
microscopic counting of spore particles using a hemocytometer to determine spore counts.           
100 % spore killing was validated by serial dilution and plate counting. 
 
Figure 1. Strategy for the chromosomal integration of the cotB-gst-streptavidin (cotB-gst-SA) gene. 
Arrows indicates direction of transcription. 
2.2.3. Immunofluorescent staining and imaging  
1 × 109 SA1 spores, 1 × 109 SA2 spores, and 109 PY79 spores were fixed with ice-cold 
paraformaldehyde 1 % for 15 min, then washed three-times with PBS (145 mM, pH 7.4). Next, 
the spores were incubated with polyclonal streptavidin-specific antibody at 10 mM for 45 min at 
RT, followed by anti-rabbit IgG conjugated Alexa 546 at 10 mM for 45 min at RT. Incubations 
with antibodies were performed in the presence of 2 % BSA and three washes with PBS (pH 7.4; 
NaCl 137 mM) plus 0.5 % BSA after the first antibody. The spores were imaged under an 
excitation of 525 nm (green laser) using a confocal fluorescence microscope Carl Zeiss 
LSM510. 
2.2.4. Western analysis of cetuximab binding 
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Biotinylated cetuximab were prepared in similar way to what described previously by 
Nguyen et al in 2012 [7]. Different amounts of biotinylated cetuximab which were prepared as 
previously described ranging from 0.25 µg, 1 µg, 4 µg to 8 µg were bound either on 1 × 109 SA1 
and 1 × 109 SA2 spores in PBS (pH7.4; NaCl, 137 mM). Incubations were made in 300 µl 
buffers for less than 1 hour and the unbound biotinylated cetuximab was removed using three 
washes with PBS (0.01 M, pH 7.4) before SDS-PAGE analysis. Biotinylated cetuximab bound 
with 2 × 108 spores (one fifth of the initial amount of spores incubated) was checked for the 
presence of a 60 kDa species indicating that DTT-reduced IgG by Western blotting using anti-
human IgG-conjugated alkaline phosphatase (Promega), and the purple color reaction 
determined using the NBT/BCIP substrate. 100 ng of biotinylated cetuximab was used as a 
positive control. The intensity of 60 kDa bands was analyzed using Scion Image® software. 
3. RESULTS AND DISCUSSION 
3.1. Cloning cotB-gst-streptavidin fusion gene into B. subtilis PY79 genome 
We started with amplification of the cotB-gst gene from the developed recombinant B. 
subtilis strain cotB-gst as mentioned in the Materials and Methods. The amplified band which 
was about 1.7 kb (data not shown) after being digested with BamHI and HindIII was then cloned 
into the vector pDG364 having the same protruding ends BamHI and HindIII.  
 
 
 
 
 
 
 
Figure 2. Screening a positive clone carrying pDG364-cotB-GST plasmid. (a) DNA electrophoresis on                
1 % agarose gel of directly PCR product from four colonies using universial primers for plasmid              
pDG364 (364 Fw and 364 Rv). Lane M: 1 kb ladder, Lane 1 - 3: negative colonies, Lane 4: positive 
colonies. (b) DNA electrophoresis on 1 % agarose gel of a directly 1.7 kb PCR product from colony                   
4 using primers specific for cotB forward primer (cotB Fw) and specific for GST reverse primer                   
(GST Rv). Lane M: 1 kb ladder, Lane 1: colony 4. 
We screened the positive recombinant pDG364-cotB-gst using direct PCR method of 
colonies growth on LB plate containing ampicillin. As shown in the Figure 2a of screening four 
colonies by PCR using universial primers of pDG364 (364 Fw and 364 Rv), we could obtain a 
a b 
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clear band of about 2.2 kb in the case for colony 4. To confirm the presence of cotB and gst 
genes in the colony 4, we used cotB Fw and GST Rv primers to amplify specific band for cotB-
gst and obtained a PCR product of about 1.7 kb (Fig. 2b, lane 1) corresponding to the total size 
1.1 kb of cotB and 0.6 kb of gst. Thus, we successfully amplified and cloned cotB-GST gene into 
pDG364 vector to form a recombinant pDG364 cotB-gst. 
In similar way, we sequentially cloned streptavidin gene into plasmid pDG364-cotB-gst via 
restriction sites HindIII and EcoRI. We amplified streptavidin gene of about 550 bp (Fig 3a) and 
cloned the enzyme digested PCR product into the pDG364-cotB-gst having the same restriction 
sites HindIII and EcoRI. We screened a positive colony using sets of primers specifically to 
cotB-gst, pDG364 plasmid, and streptavidin. As expected, we can amplified the band of 1.7 kb, 
2.2 kb, and 0.55 kb, respectively, confirming the presence of the fusion gene cotB-gst-
streptavidin in the plasmid pDG364 (Figure 3b).  The exact sequence of cotB-gst-streptavidin 
was also confirmed by DNA sequencing (data not shown). 
 
 
 
 
 
 
 
Figure 3. Cloning of streptavidin into pDG364-cotB-GST plasmid. (a) Lane M: 1 kb ladder,               
Lane 1: Electrophoresis on 1 % agarose gel of  amplified streptavidin gene from genome of 
Streptomyces avidini. (b) Electrophoresis on 1 % agarose gel of PCR product amplified directly 
from colonies. Lane M: 1kb ladder, Lane 1: PCR product from colony without pDG364 cotB-gst-
streptavidin plasmid using 364 Fw and 364 Rv, Lane 2-4: PCR product from a colony harbouring 
pDG364-CotB-gst-streptavidin using cotB Fw and GST Rv, 364 Fw and 364 Rv, and primers 
specific for streptavidin, respectively. 
Based on the capability to synthesize amylase of the B. subtilis wild strain and the inability 
of the recombinant B. subtilis because of amyE gene in B. subtilis chromosome was interrupted 
by the insertion of recombinant CotB-gst-streptavidin gene we examined this colony feature on 
LB 1 % starch plates and tested with Lugol solution. As a result, we observed the amylolytic ring 
of the wild strain PY79 whereas we did not observe any ring of the colonies of B. subtilis SA2 
(Fig. 4). The data confirm that cotB-gst-streptavidin gene was successfully integrated into the 
position of amyE sequence in chromosome of B. subtilis SA2. 
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Figure 4. Twenty eight colonies of B. subtilis SA2 and one colony of B. subtilis PY79 grown on LB             
agar containing 1 % starch overnight, then stained with Lugol solution (b), and finally being removed             
off the plate to observe amylotic ring (b). The circle in (a) indicates the position of the PY79 strain colony, 
which is corresponding to the position of clear white zone of amylotic ring in (b). 
 
 .  
 
 
 
 
 
 
 
 
 
Figure 5.  Immunofluorescence staining of spores (with or without) expressing streptavidin using primary              
anti-streptavidin rabbit IgG and secondary anti-rabbit IgG Alexa 546, and observation of fluorescent signals 
using confocal microscopy. (1) Images of emissive signals of Alexa 546 nm under green laser excitation,                   
(2) Images of signals viewed under the white light, (3) Images of merged signals from (1) and (2). 
a                                 b    
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3.2. Expression of streptavidin on the surface of recombinant B. subtilis SA2 spores 
Immunofluorescent analysis of the expression of streptavidin on the spore surface of PY79 
wild type strain, recombinant strains SA1 (CotB-streptavidin) and SA2 (CotB-GST-streptavidin) 
was performed using primary anti-streptavidin polyclonal antibody, and secondary anti-rabbit 
IgG labeled Alexa 546 (excitation: 546 nm, emission: 570 nm). We observed clear signals as 
presented by red color of Alexa 546 fluorescent dye on the spores SA1 and SA2 under green 
laser excitation. Simultaneously, these signals were merged in the position of spores observed 
under white light. By contrast, we did not observe any signal on the PY79 spores. The acquired 
results allowed us to surely affirm that the presence of streptavidin on the spore outer surface of 
both strains SA1 and SA2 with similar expression level 
3.3. Binding of biotinylated cetuximab on SA2 spores in comparison to on SA1 spores  
SA1 and SA2 spores (1 × 109) were firstly killed by autoclaving, and then tested for 
binding with cetuximab, an inhibitor of EGFR. Biotinylated anti-EGFR monoclonal IgG 
(cetuximab) at 250 ng, 1 µg, 4 µg, 8 µg were bound to spores. The unbound cetuximab was 
washed off and then 2 × 108 cetuximab bound SA1 spores were examined by SDS-PAGE 
fractionation and Western blotting (Figure 6). The DTT in the SDS-PAGE loading buffer would 
reduce the disulfide bridge of IgG, resulting in two fragments corresponding to the light and 
heavy chains.  
 
 
 
 
 
 
 
Figure 6. Western analysis of binding of biotinylated cetuximab to spores expressing streptavidin. 
Biotinylated mouse-human chimeric monoclonal IgG cetuximab at different amounts 8 µg (lane 1 and 1’), 
4 µg (lane 2 and 2’), 1 µg (lane 3 and 3’), 250 ng (lane 4 and 4’) were bound to 1 × 109 killed spores SA1 
(lane 1 - 4), and killed spores SA2 (lane 1’-4’) and total extracted proteins of  2 × 108 spores were applied 
to each well, and then were fractionated on 12 % SDS-PAGE gels and transferred to membranes and 
probed with anti-human IgG conjugated with Alkaline Phosphatase (Promega). A positive control was 100 
ng biotinylated cetuximab applied directly to the well and run in parallel (lane 3). A negative control was 
PY79 spores bound with 1 µg biotinylated cetuximab performed at parallel experiment. Molecular weight 
markers (kDa) are indicated. 
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As shown in the Figure 6, we could clearly observe a band of about 60 kDa indicating the 
size of cetuximab which was bound to the spores SA1 (Figure 6, lane 1-4) and SA2 (Figure 6, 
lane 1’-4’). The intensity of bands was in correspondence with the initial amount of biotinylated 
cetuximab incubated with the spores. The intensity of the band in Figure 6, lane 1 at 8 µg 
biotinylated cetuximab incubated with SA1 spores was equal to 50 % intensity of the control 100 
ng biotinylated cetuximab (Figure 6, lane 1), indicating that the amount of cetuximab bound on  
2 × 108 SA1 spores was about 50 ng, which implied that only about 250 ng from the 8µg of 
incubated cetuximab had bound to 1 × 109 SA1 spores. The intensity of the band in Figure 6, 
lane 1’ at 8 µg biotinylated cetuximab incubated with SA2 spores was equal to 70 % intensity of 
the control 100 ng biotinylated cetuximab (Figure 6, lane 1), indicating that the amount of 
cetuximab bound on 2 × 108 SA2 spores was about 70 ng, which implied that about 350 ng from 
the 8µg of incubated cetuximab had bound to 1 × 109 SA2 spores. Thus, the binding on SA2 was 
improved about only 1.4 fold compared to SA1. The data indicates that the binding of 
biotinylated cetuximab on SA2 spores was slightly improved compared to that on SA1 spores. 
On the other hand, PY79 did not show any observable band (Figure 6, lane 5 and 5’) 
demonstrating specific binding of biotinylated cetuximab to the streptavidin expressed as fusion 
proteins with CotB and CotB-GST on the spores SA1 and SA2, respectively. 
4. CONCLUSION 
 In sum, we successfully amplified the DNA fragments of genes coding cotB-gst and 
streptavidin-encoding gene using PCR, sequentially cloned the amplified cotB-gst and 
streptavidin gene into the pDG364 cotB plasmid and integrated the cotB-gst-streptavidin 
construct into B. subtilis genome. The expression of the streptavidin protein on the surface of B. 
subtilis SA2 spores was confirmed by Western blotting. The binding of biotinylated cetuximab 
with SA2 (cotB-GST-streptavidin) was just slightly 1.4 fold higher than that on SA1 (cotB-GST-
streptavidin) spores, indicating limited role of GST in enhancing exposure of streptavidin for 
interacting with biotinylated cetuximab. 
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TÓM TẮT 
NHÂN DÒNG VÀ BIỂU HIỆN PROTEIN DUNG HỢP GLUTATHION S TRANSFERASE-
STREPTAVIDIN TRÊN BÀO TỬ Bacillus subtilis VÀ ĐÁNH GIÁ KHẢ NĂNG GẮN               
ĐẶC HIỆU VỚI KHÁNG THỂ CETUXIMAB BIOTINYL HÓA  
Bùi Thu Thủy1, Phan Huong Trang1, Nguyễn Tràng Hiểu1, Trần Thị Mỹ1, 2, Phan Tuấn Nghĩa1, 
Nguyễn Thị Vân Anh1,  * 
1Phòng Thí nghiệm trọng điểm Công nghệ enzym và Protein,  
Trường Đại học Khoa học tự nhiên, 334 Nguyễn Trãi, Hà Nội 
2Công ty cổ phần ANABIO Research & Development, Văn Khê, Hà Đông, Hà Nội 
*Email: vananhbiolab@gmail.com 
Chúng tôi đã nhân dòng gen dung hợp (cotB-gst-streptavidin) mã hóa cho ba protein nối 
tiếp nhau bao gồm protein lớp vỏ áo của bào tử CotB, Glutathion S Transferase (GST), và 
streptavidin vào nhiễm sắc thể của Bacillus subtilis PY79 để tạo nên chủng tái tổ hợp SA2. Biểu 
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hiện của streptavidin trên lớp vỏ của bào tử SA2 spores được kiểm chứng bởi phương pháp miễn 
dịch huỳnh quang, sử dụng kháng thể sơ cấp IgG thỏ kháng streptavidin và kháng thể thứ cấp 
kháng thỏ gắn chất huỳnh quang Alexa546. Gắn bám đặc hiệu của biotinylated cetuximab lên 
bào tử của Bacillus subtilis SA1 (biểu hiện cotB-streptavidin) và lên Bacillus subtilis SA2 được 
phát hiện bởi phương pháp thẩm tách miễn dịch. Kết quả chỉ ra khả năng gắn của biotinylated 
cetuximab lên bào tử SA2 tăng lên không nhiều, khoảng 1,4 lần so với gắn lên bào tử SA1, gợi ý 
vai trò khiêm tốn của GST trong việc tăng cường sự bộc lộ của streptavidin trên bề mặt bào tử để 
tương tác với biotinylated cetuximab. 
Từ khóa: bào tử Bacillus subtilis, Glutathion S Transferase (GST), streptavidin, biotinylated 
cetuximab. 
 
